Use of Music therapy for treating depression
Recruiting
- Conditions
- Major depressive disorder, recurrent severe without psychotic features, (2) ICD-10 Condition: F331||Major depressive disorder, recurrent, moderate, (3) ICD-10 Condition: F321||Major depressive disorder, singleepisode, moderate, (4) ICD-10 Condition: F322||Major depressive disorder, singleepisode, severe without psychotic features,
- Registration Number
- CTRI/2021/08/035844
- Lead Sponsor
- MGM medical college and hospital
- Brief Summary
Randomised trial, parallel groups, to assess the effect of music therapy as add on treatment with pharmacological care for treatment of patients with depression compared to pharmacological care alone using hamilton rating scale for depression and WHO QOL survey at baseline, post therapy and at 4 month follow up, 7 sessions of 1 hour each t 10+-5 days
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
- •Patients attending OPD or IPD of psychiatry department.
- •Patients of both sex in age group of 18 to 60 years •Patients with diagnosis of moderate to severe unipolar depression (HAM-D Score >17) •Recurrent depressive disorder with current episode of moderate to severe depression.
Exclusion Criteria
- 1 Patients suffering from depression with psychotic features.
- 2 Patients with sensory impairment like hearing 3 Patients with High suicide risk (C-SSRS- positive response in the suicidal thoughts section, item 4 or 5 in last 30 days or positive response in suicidal behavior section item 6 in last 90 days) 4 Patients requiring more than two antidepressants or adjuvant medications except benzodiazepines or melatonin for sleep 5 Patients requiring any additional treatment like ECTs or psychotherapy 6 Patients with any other co morbid psychiatric or medical illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the efficacy of music therapy added to standard pharmacological care in comparison with standard pharmacological care alone, for the treatment of depression by comparing severity of depression using Hamilton rating scale for depression Baseline, post therapy or 2 and 1/2 months and 4 months follow up
- Secondary Outcome Measures
Name Time Method To assess and compare the participants Quality of life using WHO-QOL BREF scale Baseline, post therapy or 2 and 1/2 months and 4 months follow up
Trial Locations
- Locations (1)
MGM medical college and Hospital
🇮🇳Aurangabad, MAHARASHTRA, India
MGM medical college and Hospital🇮🇳Aurangabad, MAHARASHTRA, IndiaSiddhant MathurPrincipal investigator9568483045drsiddhantmathur@gmail.com